EcoDrugPlus

Phosphodiesterase 4a

Ensembl ID : ENSNBRG00000010191
Gene Symbol: PDE4A
1 Cross references
197 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSNBRG00000006662
Gene Symbol: PDE4B
3 Cross references
224 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSNBRG00000013158
Gene Symbol: PDE4D
3 Cross references
235 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSNBRG00000020393
Gene Symbol: PDE7B
4 Cross references
189 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSNBRG00000017173
Gene Symbol: PDE9A
3 Cross references
185 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSNBRG00000004658
Gene Symbol: PIK3R3
3 Cross references
171 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSNBRG00000000824
Gene Symbol: PIK3R5
3 Cross references
200 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSNBRG00000000283
Gene Symbol: PIK3R5
4 Cross references
185 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha)

Ensembl ID : ENSNBRG00000002900
Gene Symbol: PIK3R1
1 Cross references
53 Possible Orthologues:

Plasminogen Activator, Tissue Type

Ensembl ID : ENSNBRG00000020229
Gene Symbol: PLAT
3 Cross references
205 Possible Orthologues:

Plasminogen-Like

Ensembl ID : ENSNBRG00000010618
Gene Symbol: LOC102777272
3 Cross references
245 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSNBRG00000023908
Gene Symbol: PTAFR
1 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).